← back to search

Theo J. M. Ruers

The Netherlands Cancer Institute · NL
Area of research
Radiology, Nuclear Medicine and Imaging · Hepatology
Research interest
Research interests include Optical Imaging and Spectroscopy Techniques, Hepatocellular Carcinoma Treatment and Prognosis, Photoacoustic and Ultrasonic Imaging, and Infrared Thermography in Medicine.
h-index
58
citations
12,011
works
362
NIH funding
primary concept
Medicine
email

Recent publications

Design and performance of an illumination-based hyperspectral laparoscopic system.
2026cited by 0position: contributordoi
Optical Characterization of Coconut Oil from 600 nm to 1600 nm for Use as a Tissue Phantom.
2026cited by 0position: contributordoi
Separating surface reflection for calibration: implicit calibration in hyperspectral imaging
Journal of Physics: Photonics 2026cited by 0position: contributordoi
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)
ESMO Open 2025cited by 7position: lastdoi
3D Ultrasound Volume Reconstruction Using a CNN-Transformer Model and IMU Data
Lecture Notes in Computer Science 2025cited by 0position: contributordoi
Training Set Diversity: A Key Factor in AI-Driven Breast Ultrasound Classification
Lecture Notes in Computer Science 2025cited by 0position: contributordoi
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases
JAMA Oncology 2024cited by 26position: middledoi
The influence of the da Vinci surgical robot on electromagnetic tracking in a clinical environment.
2024cited by 5position: contributordoi
Spatial and Spectral Reconstruction of Breast Lumpectomy Hyperspectral Images.
2024cited by 4position: contributordoi
Resection Ratios and Tumor Eccentricity in Breast-Conserving Surgery Specimens for Surgical Accuracy Assessment.
2024cited by 2position: contributordoi
Separating Surface Reflectance from Volume Reflectance in Medical Hyperspectral Imaging.
2024cited by 1position: contributordoi
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
The Lancet Oncology 2023cited by 166position: middledoi
Toward Intraoperative Margin Assessment Using a Deep Learning-Based Approach for Automatic Tumor Segmentation in Breast Lumpectomy Ultrasound Images.
2023cited by 12position: contributordoi
Tissue Classification of Breast Cancer by Hyperspectral Unmixing.
2023cited by 7position: contributordoi
Tumor Segmentation in Colorectal Ultrasound Images Using an Ensemble Transfer Learning Model: Towards Intra-Operative Margin Assessment.
2023cited by 1position: contributordoi
An improved camera model for oblique-viewing laparoscopes: high reprojection accuracy independent of telescope rotation.
2023cited by 0position: contributordoi
Feasibility of Ex Vivo Margin Assessment with Hyperspectral Imaging during Breast-Conserving Surgery: From Imaging Tissue Slices to Imaging Lumpectomy Specimen
Applied Sciences 2021cited by 11position: contributordoi
MR-to-US Registration Using Multiclass Segmentation of Hepatic Vasculature with a Reduced 3D U-Net
Lecture Notes in Computer Science 2020cited by 24position: contributordoi
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
JNCI Journal of the National Cancer Institute 2017cited by 674position: firstdoi
Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer
European Journal of Cancer 2016cited by 82position: middledoi
The diagnostic performance of 18 F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis
Surgical Oncology 2016cited by 43position: middledoi
Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC).
Journal of Clinical Oncology 2015cited by 89position: firstdoi
O-018 Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
Annals of Oncology 2015cited by 40position: firstdoi
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
Annals of Oncology 2012cited by 436position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 15 papers (2020–2026)Behdad Dashtbozorg · Shahid Beheshti University9 papers (2021–2025)Lynn-Jade S. Jong · University of Twente7 papers (2023–2026)Henricus J C M Sterenborg · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital7 papers (2021–2026)Freija Geldof · 6 papers (2023–2025)Murielle Mauer · European Organisation for Research and Treatment of Cancer5 papers (2012–2025)Wolf O. Bechstein · Goethe University Frankfurt4 papers (2012–2017)Frits van Coevorden · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital4 papers (2012–2017)Graeme J. Poston · University of Liverpool4 papers (2012–2017)Jonathan A. Ledermann · University College London4 papers (2012–2017)Bernard Nordlinger · University of Lausanne4 papers (2012–2017) · 4 papers (2012–2017)Jean-Pierre E. N. Pierie · University Medical Center Groningen4 papers (2012–2017)Cornelis J.A. Punt · Oklahoma State University Center for Health Sciences3 papers (2012–2017)Manfred P. Lutz · European Organisation for Research and Treatment of Cancer3 papers (2012–2015)Eric Van Cutsem · KU Leuven3 papers (2012–2017)Anouk Laetitia Post · University of Amsterdam3 papers (2023–2026)Mark Witteveen · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital3 papers (2026–2026)Marie-Jeanne T. F. D. Vrancken Peeters · The Netherlands Cancer Institute2 papers (2023–2024) · 2 papers (2012–2017)